IL6 and cancer: Based on single-cell RNA sequencing, circulating CTLs from cancer patients with high plasma levels of IL-6 show suppressed functional characteristics, and IL-6-STAT3 signaling inhibits classical cytotoxic differentiation of CTLs in vitro.